OpRisk North America: Moving OTC trades onto CCPs will increase op risks

Moving OTC trades onto CCPs will increase op risks

unplugged

Panellists and speakers at the OpRisk North America conference in New York were unanimous in praising the move to clear all over-the-counter products through central counterparties (CCPs) houses as a positive development.  But they warn there are numerous systemic and operational risk issues attached.

Randall Kroszner, professor of economics at the University of Chicago Booth School of Business and former governor of the Federal Reserve System, described moving OTC derivatives onto central

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: